Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,230,000 | 1,150,000 | 1,046,000 | 870,000 | 818,000 |
| Marketable Securities | 643,000 | 487,000 | 1,038,000 | 1,106,000 | 875,000 |
| Receivables | 2,528,000 | 2,252,000 | 2,193,000 | 2,133,000 | 2,221,000 |
| Inventories | 1,594,000 | 1,589,000 | 1,614,000 | 1,441,000 | 1,502,000 |
| Other current assets | 931,000 | 990,000 | 915,000 | 941,000 | 990,000 |
| TOTAL | $6,926,000 | $6,468,000 | $6,806,000 | $6,491,000 | $6,406,000 |
| Non-Current Assets | |||||
| PPE Net | 6,023,000 | 6,005,000 | 5,764,000 | 5,639,000 | 5,543,000 |
| Investments And Advances | 1,195,000 | 1,163,000 | 1,198,000 | 606,000 | 527,000 |
| Other Non-Current Assets | 3,084,000 | 3,186,000 | 2,934,000 | 2,951,000 | 2,720,000 |
| TOTAL | $10,302,000 | $10,354,000 | $9,896,000 | $9,196,000 | $8,790,000 |
| Total Assets | $15,053,000 | $14,667,000 | $14,616,000 | $13,619,000 | $13,174,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 819,000 | 913,000 | 750,000 | 652,000 | 602,000 |
| Accrued Expenses | 403,000 | 436,000 | 437,000 | 417,000 | 389,000 |
| Other current liabilities | 1,108,000 | 1,164,000 | 1,034,000 | 1,508,000 | 1,380,000 |
| TOTAL | $5,780,000 | $5,640,000 | $6,199,000 | $5,848,000 | $5,482,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 732,000 | 687,000 | 553,000 | 583,000 | 584,000 |
| Other Non-Current Liabilities | 1,095,000 | 1,133,000 | 1,135,000 | 1,047,000 | 1,034,000 |
| TOTAL | $2,121,000 | $2,073,000 | $1,851,000 | $1,787,000 | $1,804,000 |
| Total Liabilities | $7,901,000 | $7,713,000 | $8,050,000 | $7,635,000 | $7,286,000 |
| Shareholders' Equity | |||||
| Common Shares | 35,000 | 34,000 | 34,000 | 34,000 | 34,000 |
| Retained earnings | 8,399,000 | 8,017,000 | 7,707,000 | 7,194,000 | 7,184,000 |
| Other shareholders' equity | -1,572,000 | -1,343,000 | -1,271,000 | -1,186,000 | -1,106,000 |
| TOTAL | $7,152,000 | $6,954,000 | $6,566,000 | $5,984,000 | $5,888,000 |
| Total Liabilities And Equity | $15,053,000 | $14,667,000 | $14,616,000 | $13,619,000 | $13,174,000 |